---
title: Bromhexine + Chlorpheniramine Maleate + Ephedrine
description: >-
  This combination medication is primarily used for the symptomatic relief of
  cough associated with viscous mucus and bronchospasm. It is commonly
  prescribed for conditions like acute and chronic bronchitis, asthma, and other
  respiratory tract infections where thinning mucus and bronchodilation are...
is_banned: false
lastModified: '2025-09-22T17:22:08.287Z'
faqs:
  - q: >-
      What is the recommended dosage for Bromhexine + Chlorpheniramine Maleate +
      Ephedrine?**


      **A:** The dosage varies depending on the formulation and the patient's
      age and condition. Refer to the detailed dosage guidelines above.
    a: >-
      A:** The dosage varies depending on the formulation and the patient's age
      and condition. Refer to the detailed dosage guidelines above.
  - q: >-
      Can this combination be used in asthmatic patients?**


      **A:** Use with caution due to the potential interaction of ephedrine with
      asthma medications. Close monitoring is required.
    a: >-
      A:** Use with caution due to the potential interaction of ephedrine with
      asthma medications. Close monitoring is required.
  - q: >-
      Is it safe to drive while taking this medication?**


      **A:** Caution is advised as chlorpheniramine and ephedrine can cause
      drowsiness and impair alertness.
    a: >-
      A:** Caution is advised as chlorpheniramine and ephedrine can cause
      drowsiness and impair alertness.
  - q: >-
      What should I do if I miss a dose?**


      **A:** Take the missed dose as soon as you remember, unless it is almost
      time for your next dose. Do not double the dose.
    a: >-
      A:** Take the missed dose as soon as you remember, unless it is almost
      time for your next dose. Do not double the dose.
  - q: >-
      What are the common side effects?**


      **A:**  Common side effects include drowsiness, dizziness, nausea, dry
      mouth, and headache.
    a: >-
      A:**  Common side effects include drowsiness, dizziness, nausea, dry
      mouth, and headache.
  - q: >-
      Are there any serious side effects?**


      **A:**  Rare but serious side effects include allergic reactions, cardiac
      arrhythmias, and hepatotoxicity.
    a: >-
      A:**  Rare but serious side effects include allergic reactions, cardiac
      arrhythmias, and hepatotoxicity.
  - q: >-
      Can this medication be used during pregnancy?**


      **A:**  It is generally not recommended during pregnancy, especially
      during the first trimester.  Consult a physician.
    a: >-
      A:**  It is generally not recommended during pregnancy, especially during
      the first trimester.  Consult a physician.
  - q: >-
      Can I take this medication while breastfeeding?**


      **A:** It is not recommended during breastfeeding. Components can be
      excreted in breast milk and may affect the infant.
    a: >-
      A:** It is not recommended during breastfeeding. Components can be
      excreted in breast milk and may affect the infant.
  - q: >-
      How does this medication interact with other drugs?**


      **A:** It can interact with MAOIs, antihypertensives, beta-blockers, and
      other medications. Consult a physician regarding drug interactions.
    a: >-
      A:** It can interact with MAOIs, antihypertensives, beta-blockers, and
      other medications. Consult a physician regarding drug interactions.
  - q: >-
      What are the contraindications for this combination?**


      **A:**  Contraindications include hypersensitivity, severe cardiovascular
      disease, hyperthyroidism, and concomitant use of MAOIs.
    a: >-
      A:**  Contraindications include hypersensitivity, severe cardiovascular
      disease, hyperthyroidism, and concomitant use of MAOIs.
---
## **Usage**

This combination medication is primarily used for the symptomatic relief of cough associated with viscous mucus and bronchospasm. It is commonly prescribed for conditions like acute and chronic bronchitis, asthma, and other respiratory tract infections where thinning mucus and bronchodilation are beneficial.

**Pharmacological Classification:** This combination includes drugs from three pharmacological classes:

* **Bromhexine:** Mucolytic
* **Chlorpheniramine Maleate:**  Antihistamine (first-generation)
* **Ephedrine:** Decongestant, bronchodilator, sympathomimetic amine

**Mechanism of Action:** Bromhexine breaks down disulfide bonds in mucoproteins, reducing mucus viscosity and facilitating expectoration. Chlorpheniramine maleate antagonizes histamine H1 receptors, mitigating allergic responses that contribute to bronchoconstriction and mucus secretion.  Ephedrine stimulates alpha and beta-adrenergic receptors, leading to vasoconstriction (reducing nasal congestion) and bronchodilation.

## **Alternate Names**

There are no widely recognized alternate names for this specific three-component combination. It is often referred to by its constituent drug names. Brand names vary regionally. Examples include Broxin and certain formulations of Sudin Plus.


## **How It Works**

**Pharmacodynamics:** The components work synergistically to address cough and related symptoms. Bromhexine thins the mucus, chlorpheniramine reduces allergic inflammation and secretions, while ephedrine dilates the airways and reduces congestion.

**Pharmacokinetics:**

* **Absorption:** All components are readily absorbed from the gastrointestinal tract.
* **Metabolism:** Primarily hepatic metabolism, especially for ephedrine.  Bromhexine undergoes extensive metabolism with less than 1% excreted unchanged in the urine.
* **Elimination:** Primarily renal excretion.

**Mode of Action:**

* **Bromhexine:** Depolymerizes mucopolysaccharides, reducing mucus viscosity.
* **Chlorpheniramine:** Competes with histamine for H1 receptor sites, inhibiting histamine-mediated bronchoconstriction and mucus secretion.
* **Ephedrine:**  Directly stimulates adrenergic receptors (alpha and beta), leading to bronchodilation and vasoconstriction.

**Receptor Binding/Enzyme Inhibition/Neurotransmitter Modulation:**

* **Chlorpheniramine:** H1 receptor antagonist.
* **Ephedrine:** Adrenergic receptor agonist.

**Elimination Pathways:** Predominantly renal excretion.


## **Dosage**

### **Standard Dosage**

#### **Adults:** The standard dose varies depending on the specific formulation.  A common regimen is 8-16mg of Bromhexine, 4-8mg of Chlorpheniramine Maleate, and 12.5-25mg of Ephedrine administered three to four times daily. Maximum dosages should be observed for each component.

#### **Children:** Dosage should be determined based on weight or age and according to local guidelines or product-specific recommendations.  This combination may not be suitable for all pediatric age groups.

#### **Special Cases:**

* **Elderly Patients:** Start with lower doses and monitor for adverse effects due to potential age-related changes in organ function.
* **Patients with Renal Impairment:** Dose adjustment may be needed.
* **Patients with Hepatic Dysfunction:** Use with caution and monitor liver function.
* **Patients with Comorbid Conditions:** Exercise caution with patients with hypertension, heart disease, hyperthyroidism, diabetes, glaucoma, or prostatic hypertrophy.


### **Clinical Use Cases**

Dosage in specialized settings should be guided by the patient's condition, response, and clinical protocols.  This combination is not typically specifically indicated for intubation, surgical procedures, mechanical ventilation, or emergency situations.  Individual components may have specific applications in such situations.


### **Dosage Adjustments**

Dose modifications are based on patient-specific factors, including renal and hepatic function, and potential drug interactions.



## **Side Effects**

### **Common Side Effects:**

Drowsiness, dizziness, nausea, dry mouth, headache, restlessness, insomnia, increased heart rate, anxiety, tremors.

### **Rare but Serious Side Effects:**

Allergic reactions (skin rash, hives, angioedema, anaphylaxis), hepatotoxicity (particularly with paracetamol if included in formulation), cardiac arrhythmias, bronchospasm.

### **Long-Term Effects:**

Chronic use is generally not recommended due to potential side effects and tolerance to decongestant effects.


### **Adverse Drug Reactions (ADR):**

Any severe or persistent side effects require medical attention.


## **Contraindications**

Hypersensitivity to any component; severe cardiovascular disease (e.g., angina, uncontrolled hypertension); hyperthyroidism; phaeochromocytoma; closed-angle glaucoma; severe hepatic or renal impairment; concomitant use of MAOIs.


## **Drug Interactions**

MAO inhibitors: Increased risk of hypertensive crisis; tricyclic antidepressants: Enhanced pressor effect of ephedrine; beta-blockers: Reduced bronchodilator effects of ephedrine; anticholinergic drugs: Additive anticholinergic effects; alcohol: Increased risk of hepatotoxicity (with paracetamol if present); enhanced sedative effects.



## **Pregnancy and Breastfeeding**

The safety of this combination during pregnancy and breastfeeding has not been fully established. Ephedrine may pose risks to the fetus. Bromhexine and other components may be excreted in breast milk. Consult a physician before use.  Safer alternatives may be preferred.



## **Drug Profile Summary**

* **Mechanism of Action:**  See detailed description above.
* **Side Effects:** See detailed description above.
* **Contraindications:** See detailed description above.
* **Drug Interactions:** See detailed description above.
* **Pregnancy & Breastfeeding:** Not generally recommended.
* **Dosage:** See detailed description above.
* **Monitoring Parameters:**  Blood pressure, heart rate, respiratory function, liver function (if indicated).


## **Popular Combinations**

This combination may be formulated with other ingredients such as guaifenesin (expectorant) and paracetamol (analgesic/antipyretic).  These additions further enhance the relief of cold and flu symptoms.


## **Precautions**

Pre-screening for allergies, cardiovascular disease, hyperthyroidism, and other relevant conditions. Caution is advised for elderly patients, pregnant or breastfeeding women, and children.  Alcohol should be avoided. This medication may impair alertness and driving ability.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Bromhexine + Chlorpheniramine Maleate + Ephedrine?**

**A:** The dosage varies depending on the formulation and the patient's age and condition. Refer to the detailed dosage guidelines above.

### **Q2: Can this combination be used in asthmatic patients?**

**A:** Use with caution due to the potential interaction of ephedrine with asthma medications. Close monitoring is required.

### **Q3: Is it safe to drive while taking this medication?**

**A:** Caution is advised as chlorpheniramine and ephedrine can cause drowsiness and impair alertness.

### **Q4: What should I do if I miss a dose?**

**A:** Take the missed dose as soon as you remember, unless it is almost time for your next dose. Do not double the dose.

### **Q5: What are the common side effects?**

**A:**  Common side effects include drowsiness, dizziness, nausea, dry mouth, and headache.

### **Q6:  Are there any serious side effects?**

**A:**  Rare but serious side effects include allergic reactions, cardiac arrhythmias, and hepatotoxicity.

### **Q7: Can this medication be used during pregnancy?**

**A:**  It is generally not recommended during pregnancy, especially during the first trimester.  Consult a physician.

### **Q8: Can I take this medication while breastfeeding?**

**A:** It is not recommended during breastfeeding. Components can be excreted in breast milk and may affect the infant.

### **Q9: How does this medication interact with other drugs?**

**A:** It can interact with MAOIs, antihypertensives, beta-blockers, and other medications. Consult a physician regarding drug interactions.


### **Q10: What are the contraindications for this combination?**

**A:**  Contraindications include hypersensitivity, severe cardiovascular disease, hyperthyroidism, and concomitant use of MAOIs.

